Analyst Report on Antares Pharma, OraSure Technologies, and TransEnterix Inc.
NEW YORK, NY / ACCESSWIRE / July 30, 2015 / We went searching for value among small beaten down medical device companies with strong growth opportunities before them. Antares Pharma, Inc. (NASDAQ: ATRS), OraSure Technologies, Inc. (NASDAQ: OSUR) and TransEnterix Inc. (NYSE MKT: TRXC) are young companies with compelling products in development which could lead to strong future growth for the companies and profits for investors.
An analyst report on ATRS, OSUR, and TRXC that includes a company overview, valuation, and company analysis can be viewed by using the following link at no cost.
http://bit.ly/_Medical_Device_Sector_Report
Copy and paste to browser may be required.
About Broad Street Alerts
We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a Michael McCord, Chartered Financial Analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.
CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.
Contact:
editor@broadstreetalerts.com
SOURCE: Broad Street Alerts
